Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia
- 1 February 1990
- journal article
- Published by Springer Nature in Nature
- Vol. 343 (6258) , 559-561
- https://doi.org/10.1038/343559a0
Abstract
Malignant hyperthermia (MH) is a potentially lethal condition in which sustained muscle contracture, with attendant hypercatabolic reactions and elevation in body temperature, are triggered by commonly used inhalational anaesthetics and skeletal muscle relaxants. In humans, the trait is usually inherited in an autosomal dominant fashion, but in halothane-sensitive pigs with a similar phenotype, inheritance of the disease is autosomal recessive or co-dominant. A simple and accurate non-invasive test for the gene is not available and predisposition to the disease is currently determined through a halothane- and/or caffeine-induced contracture test on a skeletal muscle biopsy. Because Ca2+ is the chief regulator of muscle contraction and metabolism, the primary defect in MH is believed to lie in Ca2+ regulation. Indeed, several studies indicate a defect in the Ca2+ release channel of the sarcoplasmic reticulum, making it a prime candidate for the altered gene product in predisposed individuals. We have recently cloned complementary DNA and genomic DNA encoding the human ryanodine receptor (the Ca2(+)-release channel of the sarcoplasmic reticulum) and mapped the ryanodine receptor gene (RYR) to region q13.1 of human chromosome 19 (ref. 14), in close proximity to genetic markers that have been shown to map near the MH susceptibility locus in humans and the halothane-sensitive gene in pigs. As a more definitive test of whether the RYR gene is a candidate gene for the human MH phenotype, we have carried out a linkage study with MH families to determine whether the MH phenotype segregates with chromosome 19q markers, including markers in the RYR gene. Co-segregation of MH with RYR markers, resulting in a lod score of 4.20 at a linkage distance of zero centimorgans, indicates that MH is likely to be caused by mutations in the RYR gene.Keywords
This publication has 20 references indexed in Scilit:
- Localization of the malignant hyperthermia susceptibility locus to human chromosome 19ql2–13.2Nature, 1990
- Fura-2 detected myoplasmic calcium and its correlation with contracture force in skeletal muscle from normal and malignant hyperthermia susceptible pigsPflügers Archiv - European Journal of Physiology, 1988
- Inheritance of Malignant Hyperthermia—A Review of Published DataPublished by Springer Nature ,1987
- Porcine Malignant Hyperthermia—The Saga of the “Hot” PigPublished by Springer Nature ,1987
- Aetiology and Pathophysiology of Malignant HyperthermiaPublished by Springer Nature ,1987
- Kinetic studies of Ca2+ release from sarcoplasmic reticulum of normal and malignant hyperthermia susceptible pig musclesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1984
- Calcium‐induced Ca2+ release from sarcoplasmic reticulum of pigs susceptible to malignant hyperthermiaFEBS Letters, 1983
- Abnormality in calcium release from skeletal sarcoplasmic reticulum of pigs susceptible to malignant hyperthermia.Journal of Clinical Investigation, 1983
- CHANGES IN THE Ca-INDUCED Ca RELEASE MECHANISM IN THE SARCOPLASMIC RETICULUM OF THE MUSCLE FROM A PATIENT WITH MALIGNANT HYPERTHERMIA Biomedical Research, 1983
- METABOLIC ERROR OF MUSCLE METABOLISM AFTER RECOVERY FROM MALIGNANT HYPERTHERMIAThe Lancet, 1970